About
Mynd Bio Australia is investing into pharmaceutical companies that develop psychotropic medicines with the intention that Mynd Biotech Portugal will manufacture & distribute during stage one into the EU &UK markets.
​
​
MYND BIO STRUCTURE
A collective group of companies bringing psychotropic medicines to the forefront of 'Best in Class' treatment options for a range of Mental Health disorders. This group brings the best minds and business operations together to deliver on developing, manufacturing & distributing patented next generation psychedelic neuromedicines to those in need.
MYNDBIO PTY LTD
AUSTRALIA
HEAD CO.
MYND PHARMACEUTICAL
PORTUGAL
PACALIS PTY LTD
AUSTRALIA
RESEARCH & DEVELOPMENT
ADKL LABS
MELBOURNE
DRUG & PATENT DEVELOPMENT
AUSTRALIAN CONTRACT
MANUFACTURER
MDMA & PSILOCYBIN
LEADING PHARMA EDUCATORS
AUSTRALIA
LEADING UNIVERSITY
FPA PATENT ATTORNEYS
AUSTRALIA
Mission
Investing into the manufacture of next generation psychedelic neuromedicines for key mental illnesses; and to supply psychedelic medicines for trials and compassionate access schemes globally.
Vision
Aims to improve manufacturing, distribution and global access to psychotropic medicines to combat, common illnesses including (but not limited to): Depression, Anxiety Disorders, Post-Traumatic Stress Disorder (PTSD), Obsessive Compulsive Disorder (OCD), Body Image and Substance Use Disorders (SUDs)
OUR PORTUGAL ROLL OUT
Target Year 1: To distribute 10kg of MDMA to pharmaceutical groups for R&D in Eu & UK.
STAGE 1
UPDATE:
Mynd Pharmaceuticals company now registered
STAGE 2
Acquire an existing building in the Algave of Portugal
Timing: Already located & identified as suitable
UPDATE:
Contract manufacturer secured in Portugal
STAGE 3
Repurpose the facility into an EUGMP - API certified facility & engage modular building company to design & build fitout.
Timing: 3 months
STAGE 4
Ordering of pharmaceutical plant & equipment to manufacture.
Timing: 3-6 months
STAGE 5
Appoint sales team to liaise with pharmarceutical companies to obtain LOI's during the build stage.
​
Commence manufacturing & distribution
Timing: 6 months post issue of license
Apply for pharmaceutical psychotropic license
Timing: 6-9 months